Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on the sale of Fiomi Diagnostics AB
Mandate

Vinge advises on the sale of Fiomi Diagnostics AB

March 05, 2012

Vinge has advised the shareholders of Fiomi Diagnostics AB in connection with the sale of the shares in the company to Trinity Biotech plc, which is quoted on NASDAQ. Fiomi, which is based in Uppsala, develops platforms for point-of-care diagnostics based on a technology which originated from Uppsala Åmice AB.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Claes Henriksson and Louise Markgren as well as project assistants Ida Norlin

Related

Vinge advises Humana in its acquisition of Team Olivia Norge AS

Humana Group ("Humana") strengthens its offering of high-quality care services in Norway as Human Care Holding AS ("Humana Norway") has entered into an agreement to acquire Team Olivia Norge AS for a purchase price of million SEK 341 on a cash- and debt-free basis.
May 17, 2024

Vinge advises Stendörren in connection with issuance of green capital securities and tender offer

 Vinge has advised Stendörren Fastigheter AB in connection with its issuance of green subordinated and perpetual capital securities in an amount of SEK 300 million (within a framework of SEK 400 million) and its parallel tender offer in respect of its previously issued capital securities.
May 17, 2024

Vinge has advised Stockholm Exergi AB in connection with the conclusion of a permanent carbon removal agreement with Microsoft, the world’s largest to date

 Vinge has advised Stockholm Exergi in connection with the conclusion of a permanent carbon removal agreement with Microsoft, covering 3.33 million tonnes of permanent carbon removals from bio-energy with carbon capture and storage (BECCS) at Värtan, Stockholm. The agreement is the world’s largest permanent carbon removal deal to date.
May 16, 2024